[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  BioMedWire [@BioMedWire](/creator/twitter/BioMedWire) on x 1296 followers Created: 2025-07-16 18:00:21 UTC $AZN experimental drug for transthyretin amyloidosis did not meet its main goal in a late-stage trial, dealing a setback in the race for rare disease treatments: #AstraZeneca #ClinicalTrials #PharmaNews #Biotech #HealthUpdate  XX engagements  **Related Topics** [azn astrazeneca](/topic/azn-astrazeneca) [manat](/topic/manat) [$azn](/topic/$azn) [stocks healthcare](/topic/stocks-healthcare) [Post Link](https://x.com/BioMedWire/status/1945544045796762094)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
BioMedWire @BioMedWire on x 1296 followers
Created: 2025-07-16 18:00:21 UTC
$AZN experimental drug for transthyretin amyloidosis did not meet its main goal in a late-stage trial, dealing a setback in the race for rare disease treatments:
#AstraZeneca #ClinicalTrials #PharmaNews #Biotech #HealthUpdate
XX engagements
Related Topics azn astrazeneca manat $azn stocks healthcare
/post/tweet::1945544045796762094